Date: Friday 7 September 2018
Location: Hilton Hotel, Glasgow
The APS at FIP conference, will be held in Glasgow, linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference which will take place in the city from the 2nd to the 6th September.
The one day APS conference will have its usual focus on the pharmaceutical sciences with the theme and session have been selected to fit in with the two of the topics of the FIP conference:
- From bench to bedside: Advancing
- Targeting special interests
We are pleased to announce this year’s science chair is
Dr Claire Thompson.
‘I am delighted to be the Science Chair of the 2018 conference which will be held in Glasgow on 7th Sep. The theme of the event is
“The Science of Differentiated Medicines” and will include sessions on:
- Age-related medicines
- Medicines and diagnostics for the developing world
- Targeted therapies
- Medicines for specialised populations
The conference will delve into the science which underpins targeting therapies for cancer, formulations for paediatric and geriatric medicines, and the innovation required to develop and deliver healthcare solutions for the poorest countries in the world.
I look forward to seeing you in Glasgow for what will be a fantastic event!
Claire is an award-winning scientist and innovator with more than 15 years’ experience in the Pharmaceutical Industry spanning the large multi-nationals GlaxoSmithKline and Pfizer, virtual and Contract Research Organisations. She is the Founder of Agility Health Tech, a consulting and communications firm which works with organisations across the healthcare space to advance their products and raise their profile. She is also Deputy Chief Scientist of the Royal Pharmaceutical Society.
Having taken a range of therapeutic products through clinical Phases 1 to 3, she thrives on translating innovative technologies into healthcare products and shaping technical and organisational strategies. She was honoured with the Royal Pharmaceutical Society’s Pharmaceutical Science Award in 2015, and the Academy of Pharmaceutical Sciences’ Medal in 2016.
Before founding Agility Health Tech, she was Head of Research and Development with Oxford PharmaScience, an AIM-listed virtual Pharmaceutical company identified as one of the "Top 10 Emerging Technology Companies 2012". Here she evaluated and identified new technologies for in-licensing, transferring them from universities/companies and directed the scale-up through CROs/CMOs in adherence to EU and FDA cGMP requirements. She also engaged with investors, manufacturing and licensing partners to build capital, product supply and revenue respectively.
Prior to this, Claire was Associate Director at Molecular Profiles (now Juniper Pharmaceuticals) and spent 7½ years at GlaxoSmithKline and Pfizer developing novel molecules and formulations for therapeutic areas such as asthma, cancer, HIV, insomnia, malaria and pain.
Claire was Chief Scientist of the Academy of Pharmaceutical Sciences from 2012 -2016. She holds Honorary Senior Lectureships in the College of Medical & Dental Sciences at the University of Birmingham and the School of Pharmacy at University College London. She holds a PhD from School of Pharmacy, University of Nottingham, and a BSc in Biochemistry from the University of St. Andrews.